Cargando…

The Etiology of Pancreatic Manifestations in Patients with Inflammatory Bowel Disease

Inflammatory bowel disease (IBD) is an idiopathic chronic and recurrent condition that comprises Crohn’s disease and ulcerative colitis. A pancreatic lesion is one of the extraintestinal lesions in patients with IBD. Acute pancreatitis is the representative manifestation, and various causes of pancr...

Descripción completa

Detalles Bibliográficos
Autores principales:	Iida, Tomoya, Wagatsuma, Kohei, Hirayama, Daisuke, Yokoyama, Yoshihiro, Nakase, Hiroshi
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2019
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6679036/ https://www.ncbi.nlm.nih.gov/pubmed/31247968 http://dx.doi.org/10.3390/jcm8070916

Ejemplares similares

Impact of Autophagy of Innate Immune Cells on Inflammatory Bowel Disease
por: Iida, Tomoya, et al.
Publicado: (2018)

Is Osteopontin a Friend or Foe of Cell Apoptosis in Inflammatory Gastrointestinal and Liver Diseases?
por: Iida, Tomoya, et al.
Publicado: (2017)

Role of Biomarkers in the Diagnosis and Treatment of Inflammatory Bowel Disease
por: Wagatsuma, Kohei, et al.
Publicado: (2021)

Immunological Mechanisms in Inflammation-Associated Colon Carcinogenesis
por: Hirano, Takehiro, et al.
Publicado: (2020)

Role of autophagy in the pathogenesis of inflammatory bowel disease
por: Iida, Tomoya, et al.
Publicado: (2017)

Current Diagnostic and Therapeutic Approaches to Cytomegalovirus Infections in Ulcerative Colitis Patients Based on Clinical and Basic Research Data
por: Yokoyama, Yoshihiro, et al.
Publicado: (2020)

Gastrointestinal involvement in a patient with familial Mediterranean fever mimicking Crohn’s disease: a case report
por: Yokoyama, Yoshihiro, et al.
Publicado: (2021)

Autophagy and Autophagy-Related Diseases: A Review
por: Ichimiya, Tadashi, et al.
Publicado: (2020)

The characteristics of gastrointestinal symptoms in patients with severe COVID-19: a systematic review and meta-analysis
por: Hayashi, Yuki, et al.
Publicado: (2021)

The Phagocytic Function of Macrophage-Enforcing Innate Immunity and Tissue Homeostasis
por: Hirayama, Daisuke, et al.
Publicado: (2017)

Correction to: The characteristics of gastrointestinal symptoms in patients with severe COVID-19: a systematic review and meta-analysis
por: Hayashi, Yuki, et al.
Publicado: (2021)

Inflammatory Bowel Disease and Colorectal Cancer: Epidemiology, Etiology, Surveillance, and Management
por: Sato, Yoshihiro, et al.
Publicado: (2023)

Artificial intelligence‐assisted endoscopy changes the definition of mucosal healing in ulcerative colitis
por: Nakase, Hiroshi, et al.
Publicado: (2020)

Pancreatic Associated Manifestations in Pediatric Inflammatory Bowel Diseases
por: Cucinotta, Ugo, et al.
Publicado: (2021)

Contradictory Effects of NLRP3 Inflammasome Regulatory Mechanisms in Colitis
por: Wagatsuma, Kohei, et al.
Publicado: (2020)

Down-regulation of RalGTPase-Activating Protein Promotes Colitis-Associated Cancer via NLRP3 Inflammasome Activation
por: Iida, Tomoya, et al.
Publicado: (2019)

Fatigue in Inflammatory Bowel Diseases: Etiologies and Management
por: Nocerino, Angelica, et al.
Publicado: (2019)

Optimizing the Use of Current Treatments and Emerging Therapeutic Approaches to Achieve Therapeutic Success in Patients with Inflammatory Bowel Disease
por: Nakase, Hiroshi
Publicado: (2020)

Dermatological Manifestations in Inflammatory Bowel Diseases
por: Antonelli, Elisabetta, et al.
Publicado: (2021)

Efficacy and safety of endoscopic procedures for common bile duct stones in patients aged 85 years or older: A retrospective study
por: Iida, Tomoya, et al.
Publicado: (2018)

Rheumatological manifestations in inflammatory bowel disease
por: Voulgari, Paraskevi V.
Publicado: (2011)

Genetic and Epigenetic Etiology of Inflammatory Bowel Disease: An Update
por: Jarmakiewicz-Czaja, Sara, et al.
Publicado: (2022)

Diversity of Gut Microbiota Affecting Serum Level of Undercarboxylated Osteocalcin in Patients with Crohn’s Disease
por: Wagatsuma, Kohei, et al.
Publicado: (2019)

Extraintestinal Manifestations of Inflammatory Bowel Disease
por: Vavricka, Stephan R., et al.
Publicado: (2015)

Can Trainees Safely Perform Endoscopic Treatments for Common Bile Duct Stones? A Single-center Retrospective Study
por: Iida, Tomoya, et al.
Publicado: (2018)

Dermatological Manifestations in Pediatric Inflammatory Bowel Disease
por: Diaconescu, Smaranda, et al.
Publicado: (2020)

Cutaneous manifestations in inflammatory bowel disease (Review)
por: Ungureanu, Loredana, et al.
Publicado: (2020)

Application of plasma alternative to serum for measuring leucine-rich α2-glycoprotein as a biomarker of inflammatory bowel disease
por: Ichimiya, Tadashi, et al.
Publicado: (2023)

Neuroinflammation as an etiological trigger for depression comorbid with inflammatory bowel disease
por: Craig, Colin F., et al.
Publicado: (2022)

Hepatobiliary manifestations of inflammatory bowel disease in children
por: Kucharska, Magdalena, et al.
Publicado: (2019)

Endocrine and metabolic manifestations in inflammatory bowel disease
por: Tigas, Stelios, et al.
Publicado: (2012)

Management of Musculoskeletal Manifestations in Inflammatory Bowel Disease
por: Sheth, Tejas, et al.
Publicado: (2015)

Clinicopathological comparison between acute gastrointestinal-graft-versus-host disease and infectious colitis in patients after hematopoietic stem cell transplantation
por: Ohwada, Sae, et al.
Publicado: (2018)

Ophthalmic manifestations in patients with inflammatory bowel disease: A review
por: Troncoso, Leandro Lopes, et al.
Publicado: (2017)

Interim analysis of a multicenter registry study of COVID-19 patients with inflammatory bowel disease in Japan (J-COSMOS)
por: Nakase, Hiroshi, et al.
Publicado: (2022)

Hepatobiliary and pancreatic manifestations in inflammatory bowel diseases: a referral center study
por: Fousekis, Fotios S., et al.
Publicado: (2019)

Musculoskeletal Clinical and Imaging Manifestations in Inflammatory Bowel Diseases
por: Sarbu, Mihaela Ionela, et al.
Publicado: (2019)

Should We Continue or Discontinue Inflammatory Bowel Disease Medication in Patients With Coronavirus Disease 2019?
por: Hayashi, Yuki, et al.
Publicado: (2022)

EP1269: INTERIM ANALYSIS OF A MULTICENTER REGISTRY STUDY OF COVID-19 INFECTED PATIENTS WITH INFLAMMATORY BOWEL DISEASE IN JAPAN (J-COSMOS).
por: Hayashi, Yuki, et al.
Publicado: (2022)

Effects of Vedolizumab Therapy on Extraintestinal Manifestations in Inflammatory Bowel Disease
por: Fleisher, Mark, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_vils4a0tkqbf6egaushccc4tmo